Systems biology approaches to a rational drug discovery paradigm

Current Topics in Medicinal Chemistry

Volumn 16, Issue 9, 2016, Pages 1009-1025

  Prathipati, Philip ^a   Mizuguchi, Kenji ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Chemogenomics; Chemoinformatics; Chemoproteomics; Drug discovery; Genomics; Phenomics; Systems biology

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; PROTEIN; LIGAND;

ARTICLE; CANCER RESEARCH; CELL SIGNALING ASSAY; CHEMOGENOMICS; CHEMOINFORMATICS; CHEMOPROTEOMICS; DRUG DESIGN; GENE EXPRESSION; GENOMICS; HUMAN; MOLECULAR BIOLOGY; PHENOMICS; QUALITATIVE RESEARCH; QUANTITATIVE ASSAY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RATIONAL DRUG DISCOVERY PARADIGM; SYSTEMS BIOLOGY; CHEMICAL STRUCTURE; DRUG DEVELOPMENT;

DRUG DISCOVERY; LIGANDS; MOLECULAR STRUCTURE; SYSTEMS BIOLOGY;

EID: 84959523909     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150826114524     Document Type: Article

References (205)

1. Prathipati, P.; Dixit, A.; Saxena, A. K. Computer Aided Drug Design: Integration of Structure Based and Ligand Based Approaches. Curr. Comput. Aided Drug Des., 2007, 92, 29-37, doi: 10.2174/157340907780809516.
2. Wolber, G.; Seidel, T.; Bendix, F.; Langer, T. Moleculepharmacophore superpositioning and pattern matching in computational drug design. Drug Discov. Today, 2008, 13 (1-2), 23-9.
3. Brustle, M.; Beck, B.; Schindler, T.; King, W.; Mitchell, T.; Clark, T., Descriptors, physical properties, and drug-likeness. J. Med. Chem., 2002, 45 (16), 3345-55;
4. (b) Tarcsay, A.; Keseru, G. M., Contributions of molecular properties to drug promiscuity. J. Med. Chem., 2013, 56 (5), 1789-95;
5. (c) Hopkins, A. L.; Keseru, G. M.; Leeson, P. D.; Rees, D. C.; Reynolds, C. H. The role of ligand efficiency metrics in drug discovery. Nat. Rev. Drug Discov., 2014, 13 (2), 105-21.
6. Nar, H. The role of structural information in the discovery of direct thrombin and factor Xa inhibitors. Trends Pharmacol. Sci., 2012, 33 (5), 279-88.
7. Pei, J.; Yin, N.; Ma, X.; Lai, L. Systems biology brings new dimensions for structure-based drug design. J. Am. Chem. Soc., 2014, 136 (33), 11556-65.
8. Dar, A. C.; Das, T. K.; Shokat, K. M.; Cagan, R. L. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature, 2012, 486 (7401), 80-4.
9. Swinney, D. C.; Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discov., 2011, 10 (7), 507-19.
10. Prathipati, P.; Ma, N. L.; Keller, T. H., Global Bayesian models for the prioritization of antitubercular agents. J. Chem. Inf. Model., 2008, 48 (12), 2362-70.
11. Prathipati, P.; Saxena, A. K., Characterization of beta3-adrenergic receptor: determination of pharmacophore and 3D QSAR model for beta3 adrenergic receptor agonism. J. Comput. Aided Mol. Des., 2005, 19 (2), 93-110;
12. (b) Prathipati, P.; Pandey, G.; Saxena, A. K., CoMFA and docking studies on glycogen phosphorylase a inhibitors as antidiabetic agents. J. Chem. Inf. Model., 2005, 45 (1), 136-45;
13. (c) Narender, T.; Shweta, S.; Tiwari, P.; Papi Reddy, K.; Khaliq, T.; Prathipati, P.; Puri, A.; Srivastava, A. K.; Chander, R.; Agarwal, S. C.; Raj, K., Antihyperglycemic and antidyslipidemic agent from Aegle marmelos. Bioorg. Med. Chem. Lett., 2007, 17 (6), 1808-11
14. (d) Sharma, P.; Singh, S.; Siddiqui, T. I.; Singh, V. S.; Kundu, B.; Prathipati, P.; Saxena, A. K.; Dikshit, D. K.; Rastogi, L.; Dixit, C.; Gupta, M. B.; Patnaik, G. K.; Dikshit, M., alpha-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents. Eur. J. Med. Chem., 2007, 42 (3), 386-93.
15. Saxena, A. K.; Prathipati, P. Collection and preparation of molecular databases for virtual screening. SAR QSAR Environ. Res., 2006, 17 (4), 371-92.
16. Prathipati, P.; Saxena, A. K. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening. J. Chem. Inf. Model., 2006, 46 (1), 39-51.
17. Durrant, J. D.; McCammon, J. A. Molecular dynamics simulations and drug discovery. BMC Biol., 2011, 9, 71.
18. Merz, K. M., Jr. Using quantum mechanical approaches to study biological systems. Acc. Chem. Res., 2014, 47 (9), 2804-11;
19. (b) Zhou, T.; Huang, D.; Caflisch, A. Quantum mechanical methods for drug design. Curr. Top. Med. Chem., 2010, 10 (1), 33-45.
20. Schames, J. R.; Henchman, R. H.; Siegel, J. S.; Sotriffer, C. A.; Ni, H.; McCammon, J. A. Discovery of a novel binding trench in HIV integrase. J. Med. Chem., 2004, 47 (8), 1879-81;
21. (b) Ivetac, A.; McCammon, J. A., Mapping the druggable allosteric space of G-protein coupled receptors: a fragment-based molecular dynamics approach. Chem. Biol. Drug Des., 2010, 76 (3), 201-17.
22. Choudhury, C.; Priyakumar, U. D.; Sastry, G. N. Dynamics based pharmacophore models for screening potential inhibitors of mycobacterial cyclopropane synthase. J. Chem. Inf. Model., 2015, 55 (4), 848-60.
23. Qu, X.; Latino, D. A.; Aires-de-Sousa, J., A big data approach to the ultra-fast prediction of DFT-calculated bond energies. J. Cheminform., 2013, 5, 34.
24. Swamidass, S. J.; Schillebeeckx, C. N.; Matlock, M.; Hurle, M. R.; Agarwal, P. Combined Analysis of Phenotypic and Target-Based Screening in Assay Networks. J. Biomol. Screen, 2014, 19 (5), 782-790.
25. Harrison, C., Phenotypic screening: A more rapid route to target deconvolution. Nat. Rev. Drug Discov., 2014, 13 (2), 102.
26. Choi, H.; Kim, J. Y.; Chang, Y. T.; Nam, H. G. Forward chemical genetic screening. Methods Mol. Biol., 2014, 1062, 393-404.
27. Vincent, F.; Loria, P.; Pregel, M.; Stanton, R.; Kitching, L.; Nocka, K.; Doyonnas, R.; Steppan, C.; Gilbert, A.; Schroeter, T.; Peakman, M. C. Developing predictive assays: The phenotypic screening "rule of 3". Sci. Transl. Med., 2015, 7 (293), 293-15.
28. Kitano, H., A robustness-based approach to systems-oriented drug design. Nat. Rev. Drug Discov., 2007, 6 (3), 202-10.
29. Deans, A. R.; Lewis, S. E.; Huala, E.; Anzaldo, S. S.; Ashburner, M.; Balhoff, J. P.; Blackburn, D. C.; Blake, J. A.; Burleigh, J. G.; Chanet, B.; Cooper, L. D.; Courtot, M.; Csosz, S.; Cui, H.; Dahdul, W.; Das, S.; Dececchi, T. A.; Dettai, A.; Diogo, R.; Druzinsky, R. E.; Dumontier, M.; Franz, N. M.; Friedrich, F.; Gkoutos, G. V.; Haendel, M.; Harmon, L. J.; Hayamizu, T. F.; He, Y.; Hines, H. M.; Ibrahim, N.; Jackson, L. M.; Jaiswal, P.; James-Zorn, C.; Kohler, S.; Lecointre, G.; Lapp, H.; Lawrence, C. J.; Le Novere, N.; Lundberg, J. G.; Macklin, J.; Mast, A. R.; Midford, P. E.; Miko, I.; Mungall, C. J.; Oellrich, A.; Osumi-Sutherland, D.; Parkinson, H.; Ramirez, M. J.; Richter, S.; Robinson, P. N.; Ruttenberg, A.; Schulz, K. S.; Segerdell, E.; Seltmann, K. C.; Sharkey, M. J.; Smith, A. D.; Smith, B.; Specht, C. D.; Squires, R. B.; Thacker, R. W.; Thessen, A.; Fernandez-Triana, J.; Vihinen, M.; Vize, P. D.; Vogt, L.; Wall, C. E.; Walls, R. L.; Westerfeld, M.; Wharton, R. A.; Wirkner, C. S.; Woolley, J. B.; Yoder, M. J.; Zorn, A. M.; Mabee, P. Finding our way through phenotypes. PLoS Biol., 2015, 13 (1), e1002033.
30. Gupta, P. B.; Onder, T. T.; Jiang, G.; Tao, K.; Kuperwasser, C.; Weinberg, R. A.; Lander, E. S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 2009, 138 (4), 645-59.
31. Waters, M. D.; Fostel, J. M. Toxicogenomics and systems toxicology: aims and prospects. Nat. Rev. Genet., 2004, 5 (12), 936-48.
32. Shang, D.; Li, C.; Yao, Q.; Yang, H.; Xu, Y.; Han, J.; Li, J.; Su, F.; Zhang, Y.; Zhang, C.; Li, D.; Li, X. Prioritizing candidate disease metabolites based on global functional relationships between me tabolites in the context of metabolic pathways. PLoS One, 2014, 9 (8), e104934.
33. Beckonert, O.; Keun, H. C.; Ebbels, T. M.; Bundy, J.; Holmes, E.; Lindon, J. C.; Nicholson, J. K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc., 2007, 2 (11), 2692-703.
34. Hollywood, K.; Brison, D. R.; Goodacre, R., Metabolomics: current technologies and future trends. Proteomics, 2006, 6 (17), 4716-23.
35. Kell, D. B. Metabolomics and systems biology: making sense of the soup. Curr. Opin. Microbiol., 2004, 7 (3), 296-307.
36. Pujol, A.; Mosca, R.; Farres, J.; Aloy, P., Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol Sci 2010, 31 (3), 115-23.
37. Faratian, D.; Clyde, R. G.; Crawford, J. W.; Harrison, D. J. Systems pathology--taking molecular pathology into a new dimension. Nat. Rev. Clin. Oncol., 2009, 6 (8), 455-64.
38. Stein, A.; Pache, R. A.; Bernado, P.; Pons, M.; Aloy, P. Dynamic interactions of proteins in complex networks: a more structured view. FEBS J., 2009, 276 (19), 5390-405.
39. Ekins, S.; Mestres, J.; Testa, B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br. J. Pharmacol., 2007, 152 (1), 9-20.
40. Vempati, U. D.; Chung, C.; Mader, C.; Koleti, A.; Datar, N.; Vidovic, D.; Wrobel, D.; Erickson, S.; Muhlich, J. L.; Berriz, G.; Benes, C. H.; Subramanian, A.; Pillai, A.; Shamu, C. E.; Schurer, S. C. Metadata Standard and Data Exchange Specifications to Describe, Model, and Integrate Complex and Diverse High- Throughput Screening Data from the Library of Integrated Network- based Cellular Signatures (LINCS). J. Biomol. Screen, 2014, 19 (5), 803-816;
41. Vidovic, D.; Koleti, A.; Schurer, S. C. Largescale integration of small molecule-induced genome-wide transcriptional responses, Kinome-wide binding affinities and cellgrowth inhibition profiles reveal global trends characterizing systems- level drug action. Front. Genet., 2014, 5 (1664-8021 (Electronic)), 342.
42. Kitano, H. Cancer robustness: tumour tactics. Nature, 2003, 426 (6963), 125;
43. Friedlander, T.; Mayo, A. E.; Tlusty, T.; Alon, U., Evolution of bow-tie architectures in biology. PLoS Comput. Biol., 2015, 11 (3), e1004055.
44. Bento, A. P.; Gaulton, A.; Hersey, A.; Bellis, L. J.; Chambers, J.; Davies, M.; Kruger, F. A.; Light, Y.; Mak, L.; McGlinchey, S.; Nowotka, M.; Papadatos, G.; Santos, R.; Overington, J. P. The ChEMBL bioactivity database: an update. Nucleic Acids Res., 2014, 42 (Database issue), D1083-90.
45. Liu, T.; Lin, Y.; Wen, X.; Jorissen, R. N.; Gilson, M. K. BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res., 2007, 35 (Database issue), D198-201.
46. Chen, Y. A.; Tripathi, L. P.; Mizuguchi, K. TargetMine, an integrated data warehouse for candidate gene prioritisation and target discovery. PLoS One 2011, 6 (3), e17844.
47. Ito, J.; Ikeda, K.; Yamada, K.; Mizuguchi, K.; Tomii, K. PoSSuM v.2.0: data update and a new function for investigating ligand analogs and target proteins of small-molecule drugs. Nucleic Acids Res., 2015, 43 (Database issue), D392-8.
48. Lamb, J.; Crawford, E. D.; Peck, D.; Modell, J. W.; Blat, I. C.; Wrobel, M. J.; Lerner, J.; Brunet, J. P.; Subramanian, A.; Ross, K. N.; Reich, M.; Hieronymus, H.; Wei, G.; Armstrong, S. A.; Haggarty, S. J.; Clemons, P. A.; Wei, R.; Carr, S. A.; Lander, E. S.; Golub, T. R. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 2006, 313 (5795), 1929-35.
49. San Lucas, F. A.; Fowler, J.; Chang, K.; Kopetz, S.; Vilar, E.; Scheet, P. Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes. Mol. Cancer Ther., 2014, 13 (12), 3230-40.
50. Nystrom-Persson, J.; Igarashi, Y.; Ito, M.; Morita, M.; Nakatsu, N.; Yamada, H.; Mizuguchi, K. Toxygates: interactive toxicity analysis on a hybrid microarray and linked data platform. Bioinformatics, 2013, 29 (23), 3080-6.
51. Subramanian, A.; Tamayo, P.; Mootha, V. K.; Mukherjee, S.; Ebert, B. L.; Gillette, M. A.; Paulovich, A.; Pomeroy, S. L.; Golub, T. R.; Lander, E. S.; Mesirov, J. P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad Sci. U. S. A., 2005, 102 (43), 15545-50.
52. Verbist, B.; Klambauer, G.; Vervoort, L.; Talloen, W.; Shkedy, Z.; Thas, O.; Bender, A.; Gohlmann, H. W.; Hochreiter, S. Using transcriptomics to guide lead optimization in drug discovery projects: Lessons learned from the QSTAR project. Drug Discov. Today, 2015, 20(5), 505-13.
53. Xia, J.; Wishart, D. S. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res., 2010, 38 (Web Server issue), W71-7.
54. Xia, J.; Mandal, R.; Sinelnikov, I. V.; Broadhurst, D.; Wishart, D. S. MetaboAnalyst 2.0--a comprehensive server for metabolomic data analysis. Nucleic Acids Res., 2012, 40 (Web Server issue), W127-33;
55. (b) Xia, J.; Wishart, D. S., Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc., 2011, 6 (6), 743-60.
56. Laenen, G.; Ardeshirdavani, A.; Moreau, Y.; Thorrez, L. Galahad: a web server for drug effect analysis from gene expression. Nucleic Acids Res., 2015, 43 (W1), W208-12.
57. Chen, E. Y.; Xu, H.; Gordonov, S.; Lim, M. P.; Perkins, M. H.; Ma'ayan, A. Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layers. Bioinformatics, 2012, 28 (1), 105-11.
58. Terfve, C.; Cokelaer, T.; Henriques, D.; MacNamara, A.; Goncalves, E.; Morris, M. K.; van Iersel, M.; Lauffenburger, D. A.; Saez-Rodriguez, J. CellNOptR: a flexible toolkit to train protein signaling networks to data using multiple logic formalisms. BMC Syst. Biol., 2012, 6, 133.
59. Liberzon, A.; Subramanian, A.; Pinchback, R.; Thorvaldsdottir, H.; Tamayo, P.; Mesirov, J. P. Molecular signatures database (MSigDB) 3.0. Bioinformatics, 2011, 27 (12), 1739-40.
60. Araki, H.; Knapp, C.; Tsai, P.; Print, C. GeneSetDB: A comprehensive meta-database, statistical and visualisation framework for gene set analysis. FEBS Open Bio 2012, 2, 76-82;
61. (b) Jiang, Z.; Gentleman, R., Extensions to gene set enrichment. Bioinformatics, 2007, 23 (3), 306-13.
62. Chen, E. Y.; Tan, C. M.; Kou, Y.; Duan, Q.; Wang, Z.; Meirelles, G. V.; Clark, N. R.; Ma'ayan, A. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics, 2013, 14, 128.
63. Sandmann, T.; Kummerfeld, S. K.; Gentleman, R.; Bourgon, R. gCMAP: user-friendly connectivity mapping with R. Bioinformatics, 2014, 30 (1), 127-8;
64. (b) Fisher, R. A., On the Interpretation of χ2 from Contingency Tables, and the Calculation of P. J. R. Stat. Soc., 1922, 85 (1), 87-94;
65. (c) Wilcoxon, F., Individual Comparisons by Ranking Methods. Biometrics Bulletin 1945, 1 (6), 80-83
66. Wu, D.; Smyth, G. K. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res., 2012, 40 (17), e133
67. Wu, D.; Lim, E.; Vaillant, F.; Asselin-Labat, M. L.; Visvader, J. E.; Smyth, G. K. ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics, 2010, 26 (17), 2176-82
68. Ritchie, M. E.; Phipson, B.; Wu, D.; Hu, Y.; Law, C. W.; Shi, W.; Smyth, G. K. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 2015, 43 (7), e47
69. Bauer, S.; Gagneur, J.; Robinson, P. N. GOing Bayesian: model-based gene set analysis of genomescale data. Nucleic Acids Res., 2010, 38 (11), 3523-32.
70. Zhao, B.; Pritchard, J. R.; Lauffenburger, D. A.; Hemann, M. T. Addressing genetic tumor heterogeneity through computationally predictive combination therapy. Cancer Discov., 2014, 4 (2), 166-74.
71. Al-Lazikani, B.; Banerji, U.; Workman, P. Combinatorial drug therapy for cancer in the post-genomic era. Nat. Biotechnol., 2012, 30 (7), 679-92.
72. Jojic, V.; Shay, T.; Sylvia, K.; Zuk, O.; Sun, X.; Kang, J.; Regev, A.; Koller, D.; Best, A. J.; Knell, J.; Goldrath, A.; Joic, V.; Koller, D.; Shay, T.; Regev, A.; Cohen, N.; Brennan, P.; Brenner, M.; Kim, F.; Rao, T. N.; Wagers, A.; Heng, T.; Ericson, J.; Rothamel, K.; Ortiz-Lopez, A.; Mathis, D.; Benoist, C.; Bezman, N. A.; Sun, J. C.; Min-Oo, G.; Kim, C. C.; Lanier, L. L.; Miller, J.; Brown, B.; Merad, M.; Gautier, E. L.; Jakubzick, C.; Randolph, G. J.; Monach, P.; Blair, D. A.; Dustin, M. L.; Shinton, S. A.; Hardy, R. R.; Laidlaw, D.; Collins, J.; Gazit, R.; Rossi, D. J.; Malhotra, N.; Sylvia, K.; Kang, J.; Kreslavsky, T.; Fletcher, A.; Elpek, K.; Bellemarte-Pelletier, A.; Malhotra, D.; Turley, S. Identification of transcriptional regulators in the mouse immune system. Nat. Immunol., 2013, 14 (6), 633-43;
73. (b) Garnett, M. J.; Edelman, E. J.; Heidorn, S. J.; Greenman, C. D.; Dastur, A.; Lau, K. W.; Greninger, P.; Thompson, I. R.; Luo, X.; Soares, J.; Liu, Q.; Iorio, F.; Surdez, D.; Chen, L.; Milano, R. J.; Bignell, G. R.; Tam, A. T.; Davies, H.; Stevenson, J. A.; Barthorpe, S.; Lutz, S. R.; Kogera, F.; Lawrence, K.; McLaren-Douglas, A.; Mitropoulos, X.; Mironenko, T.; Thi, H.; Richardson, L.; Zhou, W.; Jewitt, F.; Zhang, T.; O'Brien, P.; Boisvert, J. L.; Price, S.; Hur, W.; Yang, W.; Deng, X.; Butler, A.; Choi, H. G.; Chang, J. W.; Baselga, J.; Stamenkovic, I.; Engelman, J. A.; Sharma, S. V.; Delattre, O.; Saez-Rodriguez, J.; Gray, N. S.; Settleman, J.; Futreal, P. A.; Haber, D. A.; Stratton, M. R.; Ramaswamy, S.; McDermott, U.; Benes, C. H. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature, 2012, 483 (7391), 570-5;
74. (c) Barretina, J.; Caponigro, G.; Stransky, N.; Venkatesan, K.; Margolin, A. A.; Kim, S.; Wilson, C. J.; Lehar, J.; Kryukov, G. V.; Sonkin, D.; Reddy, A.; Liu, M.; Murray, L.; Berger, M. F.; Monahan, J. E.; Morais, P.; Meltzer, J.; Korejwa, A.; Jane-Valbuena, J.; Mapa, F. A.; Thibault, J.; Bric-Furlong, E.; Raman, P.; Shipway, A.; Engels, I. H.; Cheng, J.; Yu, G. K.; Yu, J.; Aspesi, P., Jr.; de Silva, M.; Jagtap, K.; Jones, M. D.; Wang, L.; Hatton, C.; Palescandolo, E.; Gupta, S.; Mahan, S.; Sougnez, C.; Onofrio, R. C.; Liefeld, T.; MacConaill, L.; Winckler, W.; Reich, M.; Li, N.; Mesirov, J. P.; Gabriel, S. B.; Getz, G.; Ardlie, K.; Chan, V.; Myer, V. E.; Weber, B. L.; Porter, J.; Warmuth, M.; Finan, P.; Harris, J. L.; Meyerson, M.; Golub, T. R.; Morrissey, M. P.; Sellers, W. R.; Schlegel, R.; Garraway, L. A. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 2012, 483 (7391), 603-7.
75. de Sousa Abreu, R.; Penalva, L. O.; Marcotte, E. M.; Vogel, C. Global signatures of protein and mRNA expression levels. Mol. Biosyst., 2009, 5 (12), 1512-26;
76. (b) Ning, K.; Fermin, D.; Nesvizhskii, A. I., Comparative analysis of different label-free mass spectrometry based protein abundance estimates and their correlation with RNA-Seq gene expression data. J. Proteome Res., 2012, 11 (4), 2261-71;
77. (c) Schwanhausser, B.; Busse, D.; Li, N.; Dittmar, G.; Schuchhardt, J.; Wolf, J.; Chen, W.; Selbach, M. Global quantification of mammalian gene expression control. Nature 2011, 473 (7347), 337-42
78. Vogel, C.; Marcotte, E. M., Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet., 2012, 13 (4), 227-32.
79. Deane, C. M.; Salwinski, L.; Xenarios, I.; Eisenberg, D. Protein interactions: two methods for assessment of the reliability of high throughput observations. Mol. Cell Proteomics, 2002, 1 (5), 349-56;
80. (b) Cokus, S.; Mizutani, S.; Pellegrini, M., An improved method for identifying functionally linked proteins using phylogenetic profiles. BMC Bioinformatics 2007, 8 Suppl 4, S7;
81. Jansen, R.; Yu, H.; Greenbaum, D.; Kluger, Y.; Krogan, N. J.; Chung, S.; Emili, A.; Snyder, M.; Greenblatt, J. F.; Gerstein, M. A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science, 2003, 302 (5644), 449-53
82. Wang, J.; Li, C.; Wang, E.; Wang, X., Uncovering the rules for protein-protein interactions from yeast genomic data. Proc. Natl. Acad. Sci. U. S. A., 2009, 106 (10), 3752-7
83. Xing, C.; Dunson, D. B. Bayesian inference for genomic data integration reduces misclassification rate in predicting protein-protein interactions. PLoS Comput. Biol., 2011, 7(7), e1002110.
84. Noble, D. Evolution beyond neo-Darwinism: a new conceptual framework. J. Exp. Biol., 2015, 218 (Pt 1), 7-13.
85. Franklin, S.; Vondriska, T. M. Genomes, proteomes, and the central dogma. Circ. Cardiovasc. Genet, 2011, 4 (5), 576.
86. Xie, L.; Ge, X.; Tan, H.; Xie, L.; Zhang, Y.; Hart, T.; Yang, X.; Bourne, P. E., Towards structural systems pharmacology to study complex diseases and personalized medicine. PLoS Comput. Biol., 2014, 10(5), e1003554;
87. (b) Xie, L.; Xie, L.; Bourne, P. E., Structure- based systems biology for analyzing off-target binding. Curr. Opin. Struct. Biol., 2011, 21 (2), 189-99;
88. Chang, R. L.; Xie, L.; Bourne, P. E.; Palsson, B. O. Antibacterial mechanisms identified through structural systems pharmacology. BMC Syst. Biol., 2013, 7, 102
89. Xie, L.; Evangelidis, T.; Xie, L.; Bourne, P. E. Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir. PLoS Comput. Biol., 2011, 7 (4), e1002037.
90. Fournier, M. L.; Paulson, A.; Pavelka, N.; Mosley, A. L.; Gaudenz, K.; Bradford, W. D.; Glynn, E.; Li, H.; Sardiu, M. E.; Fleharty, B.; Seidel, C.; Florens, L.; Washburn, M. P. Delayed correlation of mRNA and protein expression in rapamycin-treated cells and a role for Ggc1 in cellular sensitivity to rapamycin. Mol. Cell Proteomics, 2010, 9 (2), 271-84.
91. Goentoro, L.; Shoval, O.; Kirschner, M. W.; Alon, U. The incoherent feedforward loop can provide fold-change detection in gene regulation. Mol. Cell, 2009, 36 (5), 894-9;
92. (b) Shen-Orr, S. S.; Milo, R.; Mangan, S.; Alon, U., Network motifs in the transcriptional regulation network of Escherichia coli. Nat. Genet, 2002, 31 (1), 64-8;
93. (c) Yeger-Lotem, E.; Sattath, S.; Kashtan, N.; Itzkovitz, S.; Milo, R.; Pinter, R. Y.; Alon, U.; Margalit, H., Network motifs in integrated cellular networks of transcription-regulation and protein- protein interaction. Proc. Natl. Acad. Sci. U. S. A., 2004, 101 (16), 5934-9.
94. Iskar, M.; Campillos, M.; Kuhn, M.; Jensen, L. J.; van Noort, V.; Bork, P., Drug-induced regulation of target expression. PLoS Comput. Biol., 2010, 6 (9).
95. Koussounadis, A.; Langdon, S. P.; Um, I. H.; Harrison, D. J.; Smith, V. A., Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system. Sci. Rep., 2015, 5, 10775.
96. Choi, H.; Pavelka, N., When one and one gives more than two: challenges and opportunities of integrative omics. Front. Genet, 2011, 2, 105.
97. Creixell, P.; Schoof, E. M.; Erler, J. T.; Linding, R., Navigating cancer network attractors for tumor-specific therapy. Nat. Biotechnol., 2012, 30 (9), 842-8.
98. Kim, J.; Park, S. M.; Cho, K. H., Discovery of a kernel for controlling biomolecular regulatory networks. Sci. Rep., 2013, 3 (2045- 2322 (Electronic)), 2223.
99. Gomez-Cabrero, D.; Abugessaisa, I.; Maier, D.; Teschendorff, A.; Merkenschlager, M.; Gisel, A.; Ballestar, E.; Bongcam-Rudloff, E.; Conesa, A.; Tegner, J., Data integration in the era of omics: current and future challenges. BMC Syst. Biol., 2014, 8 Suppl 2, 11.
100. Hwang, D.; Rust, A. G.; Ramsey, S.; Smith, J. J.; Leslie, D. M.; Weston, A. D.; de Atauri, P.; Aitchison, J. D.; Hood, L.; Siegel, A. F.; Bolouri, H. A data integration methodology for systems biology. Proc. Natl. Acad. Sci. U. S. A., 2005, 102 (48), 17296-301.
101. Pavlopoulos, G. A.; Secrier, M.; Moschopoulos, C. N.; Soldatos, T. G.; Kossida, S.; Aerts, J.; Schneider, R.; Bagos, P. G. Using graph theory to analyze biological networks. BioData Min., 2011, 4, 10.
102. Bredel, M.; Jacoby, E. Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet., 2004, 5 (4), 262-75;
103. (b) Jacoby, E.; Bouhelal, R.; Gerspacher, M.; Seuwen, K. The 7 TM G-protein-coupled receptor target family. ChemMed- Chem, 2006, 1 (8), 761-82;
104. (c) Glick, M.; Jacoby, E. The role of computational methods in the identification of bioactive compounds. Curr. Opin. Chem. Biol., 2011, 15 (4), 540-6
105. Hartenfeller, M.; Eberle, M.; Meier, P.; Nieto-Oberhuber, C.; Altmann, K. H.; Schneider, G.; Jacoby, E.; Renner, S. Probing the bioactivityrelevant chemical space of robust reactions and common molecular building blocks. J. Chem. Inf. Model., 2012, 52 (5), 1167-78.
106. Wang, Y.; Suzek, T.; Zhang, J.; Wang, J.; He, S.; Cheng, T.; Shoemaker, B. A.; Gindulyte, A.; Bryant, S. H. PubChem BioAssay: 2014 update. Nucleic Acids Res., 2014, 42 (Database issue), D1075-82.
107. Backman, T. W.; Cao, Y.; Girke, T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res., 2011, 39 (Web Server issue), W486-91.
108. Matlock, M. K.; Zaretzki, J. M.; Swamidass, S. J. Scaffold network generator: a tool for mining molecular structures. Bioinformatics, 2013, 29 (20), 2655-6.
109. Cao, D. S.; Xiao, N.; Xu, Q. S.; Chen, A. F. Rcpi: R/Bioconductor package to generate various descriptors of proteins, compounds and their interactions. Bioinformatics, 2015, 31 (2), 279-81.
110. Hinselmann, G.; Rosenbaum, L.; Jahn, A.; Fechner, N.; Zell, A. jCompoundMapper: An open source Java library and commandline tool for chemical fingerprints. J. Cheminform., 2011, 3 (1), 3.
111. Langfelder, P.; Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics, 2008, 9 (1471- 2105 (Electronic)), 559.
112. Hochreiter, S.; Bodenhofer, U.; Heusel, M.; Mayr, A.; Mitterecker, A.; Kasim, A.; Khamiakova, T.; Van Sanden, S.; Lin, D.; Talloen, W.; Bijnens, L.; Gohlmann, H. W.; Shkedy, Z.; Clevert, D. A. FABIA: factor analysis for bicluster acquisition. Bioinformatics, 2010, 26 (12), 1520-7.
113. Szklarczyk, D.; Franceschini, A.; Wyder, S.; Forslund, K.; Heller, D.; Huerta-Cepas, J.; Simonovic, M.; Roth, A.; Santos, A.; Tsafou, K. P.; Kuhn, M.; Bork, P.; Jensen, L. J.; von Mering, C. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res., 2015, 43 (Database issue), D447-52.
114. Kanehisa, M.; Goto, S.; Sato, Y.; Kawashima, M.; Furumichi, M.; Tanabe, M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res., 2014, 42 (Database issue), D199-205.
115. UniProt, C. Activities at the Universal Protein Resource (UniProt). Nucleic Acids Res., 2014, 42 (Database issue), D191-8.
116. Xiao, N.; Cao, D. S.; Zhu, M. F.; Xu, Q. S. protr/ProtrWeb: R package and web server for generating various numerical representation schemes of protein sequences. Bioinformatics, 2015.
117. Smedley, D.; Haider, S.; Durinck, S.; Pandini, L.; Provero, P.; Allen, J.; Arnaiz, O.; Awedh, M. H.; Baldock, R.; Barbiera, G.; Bardou, P.; Beck, T.; Blake, A.; Bonierbale, M.; Brookes, A. J.; Bucci, G.; Buetti, I.; Burge, S.; Cabau, C.; Carlson, J. W.; Chelala, C.; Chrysostomou, C.; Cittaro, D.; Collin, O.; Cordova, R.; Cutts, R. J.; Dassi, E.; Genova, A. D.; Djari, A.; Esposito, A.; Estrella, H.; Eyras, E.; Fernandez-Banet, J.; Forbes, S.; Free, R. C.; Fujisawa, T.; Gadaleta, E.; Garcia-Manteiga, J. M.; Goodstein, D.; Gray, K.; Guerra-Assuncao, J. A.; Haggarty, B.; Han, D. J.; Han, B. W.; Harris, T.; Harshbarger, J.; Hastings, R. K.; Hayes, R. D.; Hoede, C.; Hu, S.; Hu, Z. L.; Hutchins, L.; Kan, Z.; Kawaji, H.; Keliet, A.; Kerhornou, A.; Kim, S.; Kinsella, R.; Klopp, C.; Kong, L.; Lawson, D.; Lazarevic, D.; Lee, J. H.; Letellier, T.; Li, C. Y.; Lio, P.; Liu, C. J.; Luo, J.; Maass, A.; Mariette, J.; Maurel, T.; Merella, S.; Mohamed, A. M.; Moreews, F.; Nabihoudine, I.; Ndegwa, N.; Noirot, C.; Perez-Llamas, C.; Primig, M.; Quattrone, A.; Quesneville, H.; Rambaldi, D.; Reecy, J.; Riba, M.; Rosanoff, S.; Saddiq, A. A.; Salas, E.; Sallou, O.; Shepherd, R.; Simon, R.; Sperling, L.; Spooner, W.; Staines, D. M.; Steinbach, D.; Stone, K.; Stupka, E.; Teague, J. W.; Dayem Ullah, A. Z.; Wang, J.; Ware, D.; Wong- Erasmus, M.; Youens-Clark, K.; Zadissa, A.; Zhang, S. J.; Kasprzyk, A. The BioMart community portal: an innovative alternative to large, centralized data repositories. Nucleic Acids Res., 2015.
118. Barrett, T.; Wilhite, S. E.; Ledoux, P.; Evangelista, C.; Kim, I. F.; Tomashevsky, M.; Marshall, K. A.; Phillippy, K. H.; Sherman, P. M.; Holko, M.; Yefanov, A.; Lee, H.; Zhang, N.; Robertson, C. L.; Serova, N.; Davis, S.; Soboleva, A. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res., 2013, 41 (Database issue), D991-5.
119. Gautier, L.; Cope, L.; Bolstad, B. M.; Irizarry, R. A. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 2004, 20 (3), 307-15.
120. Andrews, S. Babraham Bioinformatics -SeqMonk Mapped Sequence Analysis Tool.
121. Schaefer, M. H.; Fontaine, J. F.; Vinayagam, A.; Porras, P.; Wanker, E. E.; Andrade-Navarro, M. A. HIPPIE: Integrating protein interaction networks with experiment based quality scores. PLoS One, 2012, 7 (2), e31826.
122. Tarca, A. L.; Draghici, S.; Khatri, P.; Hassan, S. S.; Mittal, P.; Kim, J. S.; Kim, C. J.; Kusanovic, J. P.; Romero, R., A novel signaling pathway impact analysis. Bioinformatics, 2009, 25 (1), 75-82.
123. Varemo, L.; Nielsen, J.; Nookaew, I. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods. Nucleic Acids Res., 2013, 41 (8), 4378-91.
124. Dennis, G., Jr.; Sherman, B. T.; Hosack, D. A.; Yang, J.; Gao, W.; Lane, H. C.; Lempicki, R. A. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol., 2003, 4 (5), P3.
125. Krive, J.; Patel, M.; Gehm, L.; Mackey, M.; Kulstad, E.; Li, J. J.; Lussier, Y. A.; Boyd, A. D. The complexity and challenges of the International Classification of Diseases, Ninth Revision, Clinical Modification to International Classification of Diseases, 10th Revision, Clinical Modification transition in EDs. Am. J. Emerg. Med., 2015.
126. Kuhn, M.; Campillos, M.; Letunic, I.; Jensen, L. J.; Bork, P. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol., 2010, 6, 343.
127. Igarashi, Y.; Nakatsu, N.; Yamashita, T.; Ono, A.; Ohno, Y.; Urushidani, T.; Yamada, H. Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res., 2015, 43 (Database issue), D921-7.
128. Pandian, G. N.; Taniguchi, J.; Junetha, S.; Sato, S.; Han, L.; Saha, A.; AnandhaKumar, C.; Bando, T.; Nagase, H.; Vaijayanthi, T.; Taylor, R. D.; Sugiyama, H. Distinct DNA-based epigenetic switches trigger transcriptional activation of silent genes in human dermal fibroblasts. Sci. Rep., 2014, 4, 3843.
129. Ganter, B.; Snyder, R. D.; Halbert, D. N.; Lee, M. D. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. Pharmacogenomics, 2006, 7 (7), 1025-44.
130. Chelliah, V.; Juty, N.; Ajmera, I.; Ali, R.; Dumousseau, M.; Glont, M.; Hucka, M.; Jalowicki, G.; Keating, S.; Knight-Schrijver, V.; Lloret-Villas, A.; Natarajan, K. N.; Pettit, J. B.; Rodriguez, N.; Schubert, M.; Wimalaratne, S. M.; Zhao, Y.; Hermjakob, H.; Le Novere, N.; Laibe, C. BioModels: ten-year anniversary. Nucleic Acids Res., 2015, 43 (Database issue), D542-8.
131. Zhang, J. D.; Wiemann, S. KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics, 2009, 25 (11), 1470-1.
132. Mussel, C.; Hopfensitz, M.; Kestler, H. A. BoolNet--an R package for generation, reconstruction and analysis of Boolean networks. Bioinformatics, 2010, 26 (10), 1378-80.
133. Sutterlin, T.; Kolb, C.; Dickhaus, H.; Jager, D.; Grabe, N. Bridging the scales: semantic integration of quantitative SBML in graphical multi-cellular models and simulations with EPISIM and COPASI. Bioinformatics, 2013, 29 (2), 223-9.
134. Chaouiya, C.; Naldi, A.; Thieffry, D. Logical modelling of gene regulatory networks with GINsim. Methods Mol. Biol., 2012, 804, 463-79.
135. Matsuoka, Y.; Funahashi, A.; Ghosh, S.; Kitano, H., Modeling and simulation using CellDesigner. Methods Mol. Biol., 2014, 1164, 121-45.
136. Noeske, T.; Sasse, B. C.; Stark, H.; Parsons, C. G.; Weil, T.; Schneider, G. Predicting compound selectivity by self-organizing maps: cross-activities of metabotropic glutamate receptor antagonists. ChemMedChem, 2006, 1 (10), 1066-8;
137. (b) Keiser, M. J.; Setola, V.; Irwin, J. J.; Laggner, C.; Abbas, A. I.; Hufeisen, S. J.; Jensen, N. H.; Kuijer, M. B.; Matos, R. C.; Tran, T. B.; Whaley, R.; Glennon, R. A.; Hert, J.; Thomas, K. L.; Edwards, D. D.; Shoichet, B. K.; Roth, B. L. Predicting new molecular targets for known drugs. Nature, 2009, 462 (7270), 175-81;
138. (c) Reymond, J. L.; Awale, M., Exploring chemical space for drug discovery using the chemical universe database. ACS Chem. Neurosci., 2012, 3 (9), 649-57
139. Benz, R. W.; Swamidass, S. J.; Baldi, P. Discovery of power-laws in chemical space. J. Chem. Inf. Model., 2008, 48 (6), 1138-51.
140. Haupt, V. J.; Schroeder, M. Old friends in new guise: repositioning of known drugs with structural bioinformatics. Brief Bioinform., 2011, 12 (4), 312-26;
141. (b) Defranchi, E.; Schalon, C.; Messa, M.; Onofri, F.; Benfenati, F.; Rognan, D., Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements. PLoS One, 2010, 5 (8), e12214;
142. (c) Zahler, S.; Tietze, S.; Totzke, F.; Kubbutat, M.; Meijer, L.; Vollmar, A. M.; Apostolakis, J., Inverse in silico screening for identification of kinase inhibitor targets. Chem. Biol., 2007, 14 (11), 1207-14
143. Kinnings, S. L.; Liu, N.; Buchmeier, N.; Tonge, P. J.; Xie, L.; Bourne, P. E. Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput. Biol., 2009, 5(7), e1000423.
144. Akbani, R.; Ng, P. K.; Werner, H. M.; Shahmoradgoli, M.; Zhang, F.; Ju, Z.; Liu, W.; Yang, J. Y.; Yoshihara, K.; Li, J.; Ling, S.; Seviour, E. G.; Ram, P. T.; Minna, J. D.; Diao, L.; Tong, P.; Heymach, J. V.; Hill, S. M.; Dondelinger, F.; Stadler, N.; Byers, L. A.; Meric-Bernstam, F.; Weinstein, J. N.; Broom, B. M.; Verhaak, R. G.; Liang, H.; Mukherjee, S.; Lu, Y.; Mills, G. B. A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat. Commun., 2014, 5, 3887;
145. (b) Weinstein, J. N.; Collisson, E. A.; Mills, G. B.; Shaw, K. R.; Ozenberger, B. A.; Ellrott, K.; Shmulevich, I.; Sander, C.; Stuart, J. M., The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet., 2013, 45 (10), 1113-20.
146. Duran-Frigola, M.; Rossell, D.; Aloy, P., A chemo-centric view of human health and disease. Nat. Commun., 2014, 5 (2041-1723 (Electronic)), 5676;
147. Gao, Y. F.; Chen, L.; Huang, G. H.; Zhang, T.; Feng, K. Y.; Li, H. P.; Jiang, Y. Prediction of drugs target groups based on ChEBI ontology. Biomed. Res. Int., 2013, (2314- 6141 (Electronic)), 132724;
148. (c) Wu, L.; Ai, N.; Liu, Y.; Wang, Y.; Fan, X. Relating anatomical therapeutic indications by the ensemble similarity of drug sets. J. Chem. Inf. Model., 2013, 53 (8), 2154-60
149. Chen, L.; Zeng, W. M.; Cai, Y. D.; Feng, K. Y.; Chou, K. C., Predicting Anatomical Therapeutic Chemical (ATC) classification of drugs by integrating chemical-chemical interactions and similarities. PLoS One, 2012, 7 (4), e35254
150. Liu, M.; Wu, Y.; Chen, Y.; Sun, J.; Zhao, Z.; Chen, X. W.; Matheny, M. E.; Xu, H., Large-scale prediction of adverse drug reactions using chemical, biological, and phenotypic properties of drugs. J. Am. Med. Inform. Assoc., 2012, 19 (e1), e28-35.
151. Prathipati, P.; Ma, N. L.; Manjunatha, U. H.; Bender, A. Fishing the target of antitubercular compounds: in silico target deconvolution model development and validation. J. Proteome Res., 2009, 8 (6), 2788-98;
152. (b) Nettles, J. H.; Jenkins, J. L.; Bender, A.; Deng, Z.; Davies, J. W.; Glick, M. Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. J. Med. Chem., 2006, 49 (23), 6802-10;
153. (c) von der Heyde, S.; Bender, C.; Henjes, F.; Sonntag, J.; Korf, U.; Beissbarth, T. Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines. BMC Syst. Biol., 2014, 8, 75
154. Surgand, J. S.; Rodrigo, J.; Kellenberger, E.; Rognan, D., A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins, 2006, 62 (2), 509-38.
155. Dudley, J. T.; Deshpande, T.; Butte, A. J. Exploiting drugdisease relationships for computational drug repositioning. Brief Bioinform., 2011, 12 (4), 303-11;
156. (b) Suthram, S.; Dudley, J. T.; Chiang, A. P.; Chen, R.; Hastie, T. J.; Butte, A. J., Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput. Biol., 2010, 6 (2), e1000662;
157. (c) Sirota, M.; Dudley, J. T.; Kim, J.; Chiang, A. P.; Morgan, A. A.; Sweet-Cordero, A.; Sage, J.; Butte, A. J. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med., 2011, 3 (96), 96-77.
158. Costello, J. C.; Heiser, L. M.; Georgii, E.; Gonen, M.; Menden, M. P.; Wang, N. J.; Bansal, M.; Ammad-ud-din, M.; Hintsanen, P.; Khan, S. A.; Mpindi, J. P.; Kallioniemi, O.; Honkela, A.; Aittokallio, T.; Wennerberg, K.; Community, N. D.; Collins, J. J.; Gallahan, D.; Singer, D.; Saez-Rodriguez, J.; Kaski, S.; Gray, J. W.; Stolovitzky, G. A community effort to assess and improve drug sensitivity prediction algorithms. Nat. Biotechnol., 2014, 32 (12), 1202-12;
159. Li, S.; Zhang, B.; Zhang, N., Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Syst. Biol., 2011, 5 Suppl 1 (1752- 0509 (Electronic)), S10;
160. (c) Anchang, B.; Sadeh, M. J.; Jacob, J.; Tresch, A.; Vlad, M. O.; Oefner, P. J.; Spang, R. Modeling the temporal interplay of molecular signaling and gene expression by using dynamic nested effects models. Proc. Natl. Acad. Sci. U. S. A., 2009, 106 (16), 6447-52.
161. Jupp, S.; Malone, J.; Bolleman, J.; Brandizi, M.; Davies, M.; Garcia, L.; Gaulton, A.; Gehant, S.; Laibe, C.; Redaschi, N.; Wimalaratne, S. M.; Martin, M.; Le Novere, N.; Parkinson, H.; Birney, E.; Jenkinson, A. M. The EBI RDF platform: linked open data for the life sciences. Bioinformatics, 2014, 30 (9), 1338-9;
162. (b) Chen, B.; Ding, Y.; Wild, D. J. Improving integrative searching of systems chemical biology data using semantic annotation. J. Cheminform., 2012, 4 (1), 6;
163. (c) Wild, D. J.; Ding, Y.; Sheth, A. P.; Harland, L.; Gifford, E. M.; Lajiness, M. S., Systems chemical biology and the Semantic Web: what they mean for the future of drug discovery research. Drug Discov. Today, 2012, 17 (9-10), 469-74.
164. Law, V.; Knox, C.; Djoumbou, Y.; Jewison, T.; Guo, A. C.; Liu, Y.; Maciejewski, A.; Arndt, D.; Wilson, M.; Neveu, V.; Tang, A.; Gabriel, G.; Ly, C.; Adamjee, S.; Dame, Z. T.; Han, B.; Zhou, Y.; Wishart, D. S. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res., 2014, 42 (Database issue), D1091-7.
165. EBI's Example SPARQL Queries. https://www.ebi.ac.uk/rdf/example-sparql-queries (accessed April, 2015).
166. bio2rdf example SPARQL quires. https://github.com/bio2rdf/bio2rdf-scripts/wiki/Query-repository (accessed April, 2015).
167. Kalderimis, A.; Lyne, R.; Butano, D.; Contrino, S.; Lyne, M.; Heimbach, J.; Hu, F.; Smith, R.; Stepan, R.; Sullivan, J.; Micklem, G. InterMine: extensive web services for modern biology. Nucleic Acids Res., 2014, 42 (Web Server issue), W468-72.
168. TargetMine Template quires. http://targetmine.mizuguchilab.org/targetmine/templates.do?filter=Interactions (accessed April,2015).
169. Hendrickx, D. M.; Aerts, H. J.; Caiment, F.; Clark, D.; Ebbels, T. M.; Evelo, C. T.; Gmuender, H.; Hebels, D. G.; Herwig, R.; Hescheler, J.; Jennen, D. G.; Jetten, M. J.; Kanterakis, S.; Keun, H. C.; Matser, V.; Overington, J. P.; Pilicheva, E.; Sarkans, U.; Segura- Lepe, M. P.; Sotiriadou, I.; Wittenberger, T.; Wittwehr, C.; Zanzi, A.; Kleinjans, J. C. diXa: a data infrastructure for chemical safety assessment. Bioinformatics, 2015, 31 (9), 1505-7.
170. Carlson, M. R.; Zhang, B.; Fang, Z.; Mischel, P. S.; Horvath, S.; Nelson, S. F. Gene connectivity, function, and sequence conservation: predictions from modular yeast co-expression networks. BMC Genomics, 2006, 7, 40;
171. (b) Chen, Y.; Zhu, J.; Lum, P. Y.; Yang, X.; Pinto, S.; MacNeil, D. J.; Zhang, C.; Lamb, J.; Edwards, S.; Sieberts, S. K.; Leonardson, A.; Castellini, L. W.; Wang, S.; Champy, M. F.; Zhang, B.; Emilsson, V.; Doss, S.; Ghazalpour, A.; Horvath, S.; Drake, T. A.; Lusis, A. J.; Schadt, E. E., Variations in DNA elucidate molecular networks that cause disease. Nature, 2008, 452 (7186), 429-35;
172. (c) Dewey, F. E.; Perez, M. V.; Wheeler, M. T.; Watt, C.; Spin, J.; Langfelder, P.; Horvath, S.; Hannenhalli, S.; Cappola, T. P.; Ashley, E. A. Gene coexpression network topology of cardiac development, hypertrophy, and failure. Circ. Cardiovasc. Genet., 2011, 4 (1), 26-35
173. Gargalovic, P. S.; Imura, M.; Zhang, B.; Gharavi, N. M.; Clark, M. J.; Pagnon, J.; Yang, W. P.; He, A.; Truong, A.; Patel, S.; Nelson, S. F.; Horvath, S.; Berliner, J. A.; Kirchgessner, T. G.; Lusis, A. J. Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids. Proc. Natl. Acad. Sci. U. S. A., 2006, 103 (34), 12741-6
174. Ghazalpour, A.; Doss, S.; Zhang, B.; Wang, S.; Plaisier, C.; Castellanos, R.; Brozell, A.; Schadt, E. E.; Drake, T. A.; Lusis, A. J.; Horvath, S. Integrating genetic and network analysis to characterize genes related to mouse weight. PLoS Genet, 2006, 2 (8), e130
175. Gong, K. W.; Zhao, W.; Li, N.; Barajas, B.; Kleinman, M.; Sioutas, C.; Horvath, S.; Lusis, A. J.; Nel, A.; Araujo, J. A. Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells. Genome Biol., 2007, 8 (7), R149
176. Miller, J. A.; Horvath, S.; Geschwind, D. H., Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc. Natl. Acad. Sci. U. S. A., 2010, 107 (28), 12698-703
177. Oldham, M. C.; Konopka, G.; Iwamoto, K.; Langfelder, P.; Kato, T.; Horvath, S.; Geschwind, D. H. Functional organization of the transcriptome in human brain. Nat. Neurosci., 2008, 11 (11), 1271-82
178. Oldham, M. C.; Langfelder, P.; Horvath, S., Network methods for describing sample relationships in genomic datasets: application to Huntington's disease. BMC Syst. Biol., 2012, 6, 63
179. Xue, Z.; Huang, K.; Cai, C.; Cai, L.; Jiang, C. Y.; Feng, Y.; Liu, Z.; Zeng, Q.; Cheng, L.; Sun, Y. E.; Liu, J. Y.; Horvath, S.; Fan, G. Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing. Nature, 2013, 500 (7464), 593-7.
180. Meslamani, J.; Bhajun, R.; Martz, F.; Rognan, D. Computational profiling of bioactive compounds using a target-dependent composite workflow. J. Chem. Inf. Model., 2013, 53 (9), 2322-33.
181. Meslamani, J.; Li, J.; Sutter, J.; Stevens, A.; Bertrand, H. O.; Rognan, D. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling. J. Chem. Inf. Model., 2012, 52 (4), 943-55.
182. Alaimo, S.; Pulvirenti, A.; Giugno, R.; Ferro, A. Drug-target interaction prediction through domain-tuned network-based inference. Bioinformatics, 2013, 29 (16), 2004-8;
183. (b) Ding, H.; Takigawa, I.; Mamitsuka, H.; Zhu, S. Similarity-based machine learning methods for predicting drug-target interactions: a brief review. Brief Bioinform., 2014, 15 (5), 734-47;
184. (c) Pahikkala, T.; Airola, A.; Pietila, S.; Shakyawar, S.; Szwajda, A.; Tang, J.; Aittokallio, T. Toward more realistic drug-target interaction predictions. Brief Bioinform., 2015, 16 (2), 325-37.
185. Gonzalez-Diaz, H.; Prado-Prado, F.; Garcia-Mera, X.; Alonso, N.; Abeijon, P.; Caamano, O.; Yanez, M.; Munteanu, C. R.; Pazos, A.; Dea-Ayuela, M. A.; Gomez-Munoz, M. T.; Garijo, M. M.; Sansano, J.; Ubeira, F. M. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae. J. Proteome Res., 2011, 10 (4), 1698-718.
186. Keiser, M. J.; Roth, B. L.; Armbruster, B. N.; Ernsberger, P.; Irwin, J. J.; Shoichet, B. K. Relating protein pharmacology by ligand chemistry. Nat. Biotechnol., 2007, 25 (2), 197-206.
187. Yildirim, M. A.; Goh, K. I.; Cusick, M. E.; Barabasi, A. L.; Vidal, M. Drug-target network. Nat. Biotechnol., 2007, 25 (10), 1119-26.
188. Ekins, S.; Casey, A. C.; Roberts, D.; Parish, T.; Bunin, B. A. Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis. Tuberculosis (Edinb), 2014, 94 (2), 162-9;
189. (b) Ekins, S.; Freundlich, J. S.; Hobrath, J. V.; Lucile White, E.; Reynolds, R. C. Combining computational methods for hit to lead optimization in Mycobacterium tuberculosis drug discovery. Pharm. Res., 2014, 31 (2), 414-35.
190. Li, H.; Gao, Z.; Kang, L.; Zhang, H.; Yang, K.; Yu, K.; Luo, X.; Zhu, W.; Chen, K.; Shen, J.; Wang, X.; Jiang, H. TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res., 2006, 34 (Web Server issue), W219-24.
191. Martinez-Jimenez, F.; Marti-Renom, M. A. Ligand-target prediction by structural network biology using nAnnoLyze. PLoS Comput. Biol., 2015, 11 (3), e1004157.
192. Campillos, M.; Kuhn, M.; Gavin, A. C.; Jensen, L. J.; Bork, P. Drug target identification using side-effect similarity. Science, 2008, 321 (5886), 263-6.
193. Iorio, F.; Bosotti, R.; Scacheri, E.; Belcastro, V.; Mithbaokar, P.; Ferriero, R.; Murino, L.; Tagliaferri, R.; Brunetti-Pierri, N.; Isacchi, A.; di Bernardo, D. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sci. U. S. A., 2010, 107 (33), 14621-6.
194. Fernald, G. H.; Altman, R. B. Using molecular features of xenobiotics to predict hepatic gene expression response. J. Chem. Inf. Model, 2013, 53 (10), 2765-73.
195. Jacoby, E.; Tresadern, G.; Bembenek, S.; Wroblowski, B.; Buyck, C.; Neefs, J. M.; Rassokhin, D.; Poncelet, A.; Hunt, J.; van Vlijmen, H. Extending kinome coverage by analysis of kinase inhibitor broad profiling data. Drug Discov. Today, 2015.
196. Clark, A. M.; Sarker, M.; Ekins, S. New target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0. J. Cheminform, 2014, 6, 38.
197. Cheng, F.; Liu, C.; Jiang, J.; Lu, W.; Li, W.; Liu, G.; Zhou, W.; Huang, J.; Tang, Y. Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol., 2012, 8 (5), e1002503.
198. Zhou, T.; Ren, J.; Medo, M.; Zhang, Y. C. Bipartite network projection and personal recommendation. Phys. Rev. E. Stat. Nonlin. Soft Matter Phys., 2007, 76 (4 Pt 2), 046-115.
199. van Laarhoven, T.; Nabuurs, S. B.; Marchiori, E. Gaussian interaction profile kernels for predicting drug-target interaction. Bioinformatics, 2011, 27 (21), 3036-43.
200. Mei, J. P.; Kwoh, C. K.; Yang, P.; Li, X. L.; Zheng, J. Drug-target interaction prediction by learning from local information and neighbors. Bioinformatics, 2013, 29 (2), 238-45.
201. Yamanishi, Y.; Araki, M.; Gutteridge, A.; Honda, W.; Kanehisa, M. Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 2008, 24 (13), i232-40.
202. Nidhi Glick, M.; Davies, J. W.; Jenkins, J. L. Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J. Chem. Inf. Model., 2006, 46 (3), 1124-33.
203. Wale, N.; Karypis, G. Target fishing for chemical compounds using target-ligand activity data and ranking based methods. J. Chem. Inf. Model., 2009, 49 (10), 2190-201.
204. Pan, Y.; Cheng, T.; Wang, Y.; Bryant, S. H. Pathway analysis for drug repositioning based on public database mining. J. Chem. Inf. Model., 2014, 54 (2), 407-18.
205. Han, S.; Kim, D. Inference of protein complex activities from chemical-genetic profile and its applications: predicting drug-target pathways. PLoS Comput. Biol., 2008, 4 (8), e1000162.